Criteo SA
14 nominees · 4 ballot items.
Shareholders will vote on approval of the cross-border merger and related merger documents, discharge of the directors, approval of the 2027 Omnibus Incentive Plan and its initial share reserve, and authorization for the board or its designees to complete the merger-related filings and actions.
On the ballot4
- 1
Merger Proposal
ManagementBoard: FORApprove the cross-border merger of Lux Criteo with and into Criteo Holdings, Inc., with U.S. Criteo surviving, and approve and adopt the Merger Agreement and Common Draft Terms, after acknowledging the required conflict-of-interest report and availability of required merger documents and accounts.
More detail
The Merger Proposal asks shareholders to approve the cross-border merger of Lux Criteo into its wholly owned Delaware subsidiary, Criteo Holdings, Inc., with the subsidiary surviving as the public company. It also asks shareholders to approve and adopt the August 5, 2026 Merger Agreement and Common Draft Terms of Cross-Border Merger. The proposal incorporates Luxembourg’s required procedural steps, including acknowledgment of the board conflict-of-interest report and confirmation that the merger reports, independent expert report, transaction documents and accounts were made available for inspection. At the effective time, Lux Criteo would dissolve without liquidation, its assets and liabilities would vest in U.S. Criteo, and outstanding ordinary shares would be exchanged one-for-one for U.S. Criteo common stock. The surviving company is expected to list its common stock on the NYSE under the existing CRTO symbol, replacing the Nasdaq listing. Management is seeking approval to complete the planned redomiciliation from Luxembourg to Delaware, which it believes could facilitate broader inclusion in major U.S. stock indices and improve access to passive capital. The transaction is subject to shareholder approval and other conditions, including effectiveness of the Form S-4, exchange listing approval, absence of prohibitive laws or orders, and required governmental authorizations. The proposal requires a two-thirds majority of votes cast after satisfaction of the applicable quorum. The board recommends voting FOR because it believes the merger and related documents are in the best interests of Lux Criteo and its shareholders.
- 2
Discharge Proposal
ManagementBoard: FORGrant a discharge (quitus) to the directors of Lux Criteo for the performance of their mandates from January 1, 2026 through the date of the General Meeting.
More detail
The Discharge Proposal asks shareholders to grant the directors of Lux Criteo a discharge, or quitus, for their mandates during the period from January 1, 2026 through the General Meeting. Under Luxembourg law, a discharge generally operates as a waiver of the company’s right to seek damages from directors for matters covered by the discharge. It does not eliminate the directors’ potential liability to third parties. The discharge is effective only if the accounts presented to shareholders contain no omissions or false information concealing the company’s true situation and if actions outside the articles of association were properly disclosed in the convening notice. The proposal is being presented in the context of the company’s planned merger and transition from Luxembourg to Delaware. Approval would provide the directors with the customary corporate release for their service during the specified period before the merger takes effect. Minority shareholders holding at least 10% of voting rights may retain the ability to bring a derivative action on behalf of the company under Luxembourg law. The proposal is independent of the Merger Proposal and is not conditioned on approval of another proposal. The board recommends voting FOR the discharge, consistent with its recommendation on all matters before the meeting.
- 3
Omnibus Plan Proposal
ManagementBoard: FORApprove the Criteo Holdings, Inc. 2027 Omnibus Incentive Plan, including authorization of its initial share reserve, for equity and other incentive awards following the merger.
More detail
The Omnibus Plan Proposal asks shareholders to approve the Criteo Holdings, Inc. 2027 Omnibus Incentive Plan and authorize its initial share reserve. The plan is intended to become effective at the merger’s effective time and govern future equity awards by the Delaware surviving corporation. It permits options, stock appreciation rights, restricted stock, restricted stock units, stock bonuses, other stock-based awards and cash awards for employees, officers, non-employee directors, consultants and independent contractors. The proposed share reserve is 5,130,000 shares, subject to a reduction for awards granted under the prior plans before the new plan becomes effective. Management cites recruiting, retention, performance alignment and long-term growth incentives as the principal reasons for adopting the plan. The plan includes governance features such as a 12-month minimum vesting period for most awards, no evergreen replenishment, no discounted options, no repricing without shareholder approval, limits on director compensation and clawback provisions. Existing awards under the prior shareholder-approved plans would be assumed and converted one-for-one into awards relating to U.S. Criteo common stock, while the prior plans would no longer be used for new grants. Approval is conditioned on approval of the Merger Proposal, reflecting that the plan is designed for the post-merger Delaware company. The board recommends voting FOR because it views the plan as necessary to maintain an effective equity-based compensation program and support the company’s ability to attract, retain and incentivize personnel.
- 4
Delegation Proposal
ManagementBoard: FORAuthorize the board of directors or its designees, acting individually with substitution authority, to complete the notarial acknowledgment and all filings, notifications, publications and other actions needed to implement the merger and related proposals.
More detail
The Delegation Proposal asks shareholders to authorize the Lux Criteo board or any authorized designee to carry out the formal steps needed to implement the merger. The authority includes appearing before a Luxembourg notary to execute the acknowledgment, or constat, deed confirming that the merger conditions have been satisfied or waived. It also covers filings, notifications, publications and other actions considered necessary or advisable in connection with the merger and related proposals. The authorization may be exercised individually and severally, with full power of substitution, providing flexibility for implementation logistics. The proposal is intended to avoid requiring a further shareholder vote for ministerial or execution-related steps after the substantive approvals are obtained. It is particularly relevant because Luxembourg merger law requires formal documentation and confirmation of the conditions precedent. The proposal does not itself approve the economic terms of the merger; those terms are addressed principally in the Merger Proposal. Approval is expressly conditioned on approval of the Merger Proposal. The board recommends voting FOR because the delegation would facilitate timely completion of the approved transaction and related filings.
Nominees on the ballot14
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Neuberger Berman Group LLC | 16.3% | 7,995,682 | $146M |
| 2 | DnB Asset Management AS | 12.2% | 5,998,091 | $110M |
| 3 | Senvest Management, LLC | 9.4% | 4,597,322 | $84M |
| 4 | MORGAN STANLEY | 5.7% | 2,801,274 | $51M |
| 5 | BlueCrest Capital Management Ltd | 4.6% | 2,260,000 | $41M |
| 6 | ACADIAN ASSET MANAGEMENT LLC | 4.3% | 2,095,486 | $38M |
| 7 | MORGAN STANLEY | 4.2% | 2,041,377 | $37M |
| 8 | Jupiter Topco LLC | 3.6% | 1,784,972 | $33M |
| 9 | AMERICAN CENTURY COMPANIES INC | 3.2% | 1,557,820 | $28M |
| 10 | Nierenberg Investment Management Company, LLCActivist | 2.1% | 1,052,787 | $19M |
Other Communication Services sector meetings6
Upcoming shareholder meetings at Criteo SA’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Criteo SA 2026 special meeting?
- Criteo SA (CRTO) holds its 2026 special shareholder meeting on Tuesday, December 29, 2026.
- What is the record date for the Criteo SA 2026 meeting?
- The record date for the Criteo SA 2026 meeting is Thursday, October 22, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Criteo SA's 2026 meeting?
- The board is presenting 14 director nominees at the Criteo SA 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Criteo SA 2026 meeting?
- Shareholders will vote on 4 proposals at the Criteo SA 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.